126 related articles for article (PubMed ID: 36511434)
1. Bayesian sample size calculations for comparing two strategies in SMART studies.
Turchetta A; Moodie EEM; Stephens DA; Lambert SD
Biometrics; 2023 Sep; 79(3):2489-2502. PubMed ID: 36511434
[TBL] [Abstract][Full Text] [Related]
2. Interim monitoring in sequential multiple assignment randomized trials.
Wu L; Wang J; Wahed AS
Biometrics; 2023 Mar; 79(1):368-380. PubMed ID: 34571583
[TBL] [Abstract][Full Text] [Related]
3. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
Lewis RJ; Lipsky AM; Berry DA
Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
[TBL] [Abstract][Full Text] [Related]
4. Bayesian set of best dynamic treatment regimes: Construction and sample size calculation for SMARTs with binary outcomes.
Artman WJ; Johnson BA; Lynch KG; McKay JR; Ertefaie A
Stat Med; 2022 Apr; 41(9):1688-1708. PubMed ID: 35124836
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
Moatti M; Chevret S; Zohar S; Rosenberger WF
Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Bayesian methods for pilot studies.
Willan AR; Thabane L
Clin Trials; 2020 Aug; 17(4):414-419. PubMed ID: 32297539
[TBL] [Abstract][Full Text] [Related]
8. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
Ciarleglio MM; Arendt CD
Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
[TBL] [Abstract][Full Text] [Related]
9. Design of sequentially randomized trials for testing adaptive treatment strategies.
Ogbagaber SB; Karp J; Wahed AS
Stat Med; 2016 Mar; 35(6):840-58. PubMed ID: 26412033
[TBL] [Abstract][Full Text] [Related]
10. Sample size calculation based on precision for pilot sequential multiple assignment randomized trial (SMART).
Yan X; Ghosh P; Chakraborty B
Biom J; 2021 Feb; 63(2):247-271. PubMed ID: 32529788
[TBL] [Abstract][Full Text] [Related]
11. Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive power.
Liu Q; Hu G; Ye B; Wang S; Wu Y
Pharm Stat; 2023 Mar; 22(2):349-364. PubMed ID: 36418025
[TBL] [Abstract][Full Text] [Related]
12. Sample size calculations for evaluating treatment policies in multi-stage designs.
Dawson R; Lavori PW
Clin Trials; 2010 Dec; 7(6):643-52. PubMed ID: 20630903
[TBL] [Abstract][Full Text] [Related]
13. Frequentist operating characteristics of Bayesian optimal designs via simulation.
Zhang Y; Trippa L; Parmigiani G
Stat Med; 2019 Sep; 38(21):4026-4039. PubMed ID: 31215685
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
15. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
Zhan D; Ouyang Y; Xu L; Wong H
Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
[TBL] [Abstract][Full Text] [Related]
16. A group-sequential randomized trial design utilizing supplemental trial data.
Kotalik A; Vock DM; Hobbs BP; Koopmeiners JS
Stat Med; 2022 Feb; 41(4):698-718. PubMed ID: 34755388
[TBL] [Abstract][Full Text] [Related]
17. Sample size determination for Bayesian analysis of small n sequential, multiple assignment, randomized trials (snSMARTs) with three agents.
Wei B; Braun TM; Tamura RN; Kidwell K
J Biopharm Stat; 2020 Nov; 30(6):1109-1120. PubMed ID: 32892710
[TBL] [Abstract][Full Text] [Related]
18. Bayesian sample size re-estimation using power priors.
Brakenhoff TB; Roes K; Nikolakopoulos S
Stat Methods Med Res; 2019 Jun; 28(6):1664-1675. PubMed ID: 29717945
[TBL] [Abstract][Full Text] [Related]
19. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data.
Zhang W; Pan Z; Yuan Y
J Biopharm Stat; 2022 May; 32(3):359-372. PubMed ID: 35679137
[TBL] [Abstract][Full Text] [Related]
20. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
Gordon Lan KK; Wittes JT
Clin Trials; 2012 Oct; 9(5):561-9. PubMed ID: 22865839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
